Concepedia

Greg Conley

GC

Statistics

Publications

6

Citations

576

H-Index

6

Active since

2002

Affiliations

Dynavax Technologies (Germany)(Current)

Greg Conley is an author at Dynavax Technologies (Germany) specializing in pharmacy, biochemistry, and protein engineering.

Publications per year

2002–2011

6

Publications

6

Novel Peptide Inhibitors of Angiotensin-converting Enzyme 2

Lili Huang, Daniel J. Sexton, Kirsten Skogerson et al. · Journal of Biological Chemistry · 2003 · 222 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

The distinctive separation attributes of mixed-mode resins and their application in monoclonal antibody downstream purification process

Jie Chen, Jen Tetrault, Yanyu Zhang et al. · Journal of Chromatography A · 2009 · 139 citations

Pharmacy, Biochemistry, Chemical Engineering +16

Development of Mammalian Serum Albumin Affinity Purification Media by Peptide Phage Display

Aaron K. Sato, Daniel J. Sexton, Lee A. Morganelli et al. · Biotechnology Progress · 2002 · 89 citations

Life Sciences, Biochemistry, Chemical Biology +17

A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases

Ajay Shrivastava, Mathew A. von Wronski, Aaron K. Sato et al. · Protein Engineering Design and Selection · 2005 · 53 citations

Pharmacy, Biochemistry, Medicinal Chemistry +17

A Human Monoclonal Antibody against Insulin-Like Growth Factor-II Blocks the Growth of Human Hepatocellular Carcinoma Cell Lines <i>In vitro</i> and <i>In vivo</i>

Daniel T. Dransfield, Edward H. Cohen, Qing Chang et al. · Molecular Cancer Therapeutics · 2010 · 48 citations

Medicine, Endocrinology, Oncology +14

1–5 of 6